Jeffrey W. Albers
2016
In 2016, Jeffrey W. Albers earned a total compensation of $2.2M as President and Chief Executive Officer at Blueprint Medicines, a 63% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $273,125 |
|---|---|
| Option Awards | $1,407,644 |
| Salary | $476,827 |
| Other | $9,000 |
| Total | $2,166,596 |
Albers received $1.4M in option awards, accounting for 65% of the total pay in 2016.
Albers also received $273.1K in non-equity incentive plan, $476.8K in salary and $9K in other compensation.
Rankings
In 2016, Jeffrey W. Albers' compensation ranked 4,528th out of 14,075 executives tracked by ExecPay. In other words, Albers earned more than 67.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,528 out of 14,075 | 68th |
Division Manufacturing | 1,608 out of 5,489 | 71st |
Major group Chemicals And Allied Products | 499 out of 1,895 | 74th |
Industry group Drugs | 368 out of 1,538 | 76th |
Industry Pharmaceutical Preparations | 291 out of 1,176 | 75th |
Source: SEC filing on April 28, 2017.
Albers' colleagues
We found five more compensation records of executives who worked with Jeffrey W. Albers at Blueprint Medicines in 2016.
2016
Marion Dorsch
Blueprint Medicines
Chief Scientific Officer
2016
Tracey McCain
Blueprint Medicines
Chief Legal Officer
2016
Kate Haviland
Blueprint Medicines
Chief Business Officer
2016
Anthony Boral
Blueprint Medicines
Chief Medical Officer
2016
Michael Landsittel
Blueprint Medicines